Clinical effect of human pituitary follicle-stimulating hormone (FSH).
about
Gonadotrophins for ovulation induction in women with polycystic ovarian syndromeRecombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndromeGonadotrophins for ovulation induction in women with polycystic ovarian syndromeHighly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilizationMixed protocols: multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe.Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization.Anovulation and ovulation induction.Recombinant follitropin alfa/lutropin alfa in fertility treatment.A historical perspective of the clinical evolution of the assisted reproductive technologies.TESTOSTERONE PRODUCTION RATES IN NORMAL ADULTS.Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile womenRecombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.History and challenges surrounding ovarian stimulation in the treatment of infertility.Progress in ovulation induction with gonadotropins.Acute appendicitis with subsequent infertility.Androgen secretion in the Stein-Leventhal syndrome.Historical perspectives in gonadotrophin therapy.Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.Recent advances in the management of infertility of women.Clinical results with human gonadotrophins in anovulation, using two alternative dosage schemes.Dynamic changes in glycosylation and glycan composition of serum FSH and LH during natural ovarian stimulation.Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.The treatment of oligospermia with various dosage regimes of gonadotropins.Induction of ovulation with gonadotrophins--a ten year review.The clinical uses of human gonadotrophins.The laboratory control of the induction of ovulation.Allergic reaction to a highly purified urinary follicle stimulating hormone preparation in controlled ovarian hyperstimulation for in vitro fertilization.The pituitary through the ages--a gynaecologists view.Comparison of hCG versus GnRH analog for releasing oocytes following ultra low-dose gonadotropin stimulation.PURIFICATION OF FOLLICLE-STIMULATING HORMONE FROM HUMAN ANTERIOR PITUITARY GLANDS.Gonadotropin stimulation: past, present and future.Emergency hypophysectomy in pregnancy after induction of ovulation.Expected advances in human fertility treatments and their likely translational consequences.
P2860
Q24187261-299EE815-77FA-4647-B316-724A5F825927Q24188049-1F3FF567-D249-43DE-BC18-0B4BB8931B73Q24202664-06CFB856-111C-49EA-9EDE-DEB2DDCC58ADQ24791383-61A76EE3-37AE-40EA-B432-1EF8097B46C1Q24814392-7C2DD5B0-0DC7-4D7C-8DB9-44B579D7799BQ24815871-F87CF35A-687E-441D-8D26-E773524F805FQ33598521-5134F69A-8F45-4072-9F3A-7129DD7820ADQ33644799-63CF3CCD-4D72-41EE-9E57-AA717658317FQ33843867-7DFA282D-8E60-40D9-89AB-CC5E45779A21Q33950847-CC58D691-1CD6-4D80-B594-5EC2B1432B5BQ34272037-407BD25D-987B-4CE9-93ED-894BBD15E2B0Q34281880-F34ED563-7AD6-4073-A7E1-07E5FAC642A7Q34351681-76E7F832-CC66-4622-BAAE-E958C8264C1AQ35657679-B5EEEBD4-300F-440F-AD98-B27B0242521EQ35797103-7B62A73A-6361-4A5B-B56A-9C6AC3F5F0C3Q35859863-E8A827B2-054F-43CA-8313-B945AAE2C086Q35896964-CCB7CC97-492D-4BA0-B043-EFDA530ADF9EQ36136018-64B245F8-633C-41BA-90F5-0610529132E7Q36522427-D9412157-FFA5-4890-9B4B-61717C894C02Q36809078-9443B268-2A0A-4CBD-9BED-F7444E3D103BQ37019056-00D0F6B5-39D3-4C81-A794-86E11F341949Q37381361-207B53B2-547D-462B-A97D-66AA6CACA4ACQ39097566-49DA10B4-45A9-4F27-8DF9-279FE5983AF2Q40216044-2D52365D-E6BE-487E-B368-6776D5E83737Q45024001-B181E7AE-AA7F-4C33-BA74-F38F3029509BQ45298676-87470AAD-98DD-43C9-B983-04A6184EF402Q48886335-D010FC1C-365A-41E9-BFC8-9C897B0A0816Q49068787-97FC79E5-0742-421C-A7AE-26FF44950FCCQ49143750-F513E88C-75C8-4EBA-8D5C-F3D039D45604Q51273681-1964F020-8ED8-4E94-97B1-AEAF13704D83Q55255771-3E0CA5AC-EAA8-4D10-99CE-F93E5E1E7F42Q55288900-FFFA36E3-AE7B-4FE5-A6C3-29E63DB6AAD9Q55491545-DF1FE279-E12C-4A05-9455-F770D4894FCD
P2860
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
description
1958 nî lūn-bûn
@nan
1958 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1958 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1958年の論文
@ja
1958年論文
@yue
1958年論文
@zh-hant
1958年論文
@zh-hk
1958年論文
@zh-mo
1958年論文
@zh-tw
1958年论文
@wuu
name
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@ast
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@en
Clinical effect of human pituitary follicle-stimulating hormone
@nl
type
label
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@ast
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@en
Clinical effect of human pituitary follicle-stimulating hormone
@nl
prefLabel
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@ast
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@en
Clinical effect of human pituitary follicle-stimulating hormone
@nl
P2093
P356
P1476
Clinical effect of human pituitary follicle-stimulating hormone (FSH).
@en
P2093
DICZFALUSY E
GEMZELL CA
TILLINGER G
P304
P356
10.1210/JCEM-18-12-1333
P407
P577
1958-12-01T00:00:00Z